685535-22-2 Usage
Uses
Used in Pharmaceutical Industry:
Phenol, 4-chloro-5-ethoxy-2-nitro-, is used as an intermediate in the synthesis of various pharmaceuticals for its ability to contribute to the development of new drugs with specific therapeutic properties.
Used in Pesticide Industry:
In the pesticide industry, Phenol, 4-chloro-5-ethoxy-2-nitro-, is employed as a chemical intermediate to formulate effective pest control agents, leveraging its potential to enhance the performance of these products.
Used in Dye Industry:
Phenol, 4-chloro-5-ethoxy-2-nitro-, is utilized in the dye industry as an intermediate in the production of various dyes, contributing to the colorfastness and stability of the final products.
Used as a Disinfectant and Antiseptic:
Due to its antimicrobial properties, Phenol, 4-chloro-5-ethoxy-2-nitro-, is used as a disinfectant and antiseptic in various settings, including medical and industrial applications, to prevent the spread of infections.
However, it is important to note that Phenol, 4-chloro-5-ethoxy-2-nitro-, is considered toxic and may cause skin irritation, respiratory issues, and other adverse effects if not handled properly. Therefore, it requires careful handling and appropriate safety measures during its use in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 685535-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,8,5,5,3 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 685535-22:
(8*6)+(7*8)+(6*5)+(5*5)+(4*3)+(3*5)+(2*2)+(1*2)=192
192 % 10 = 2
So 685535-22-2 is a valid CAS Registry Number.
685535-22-2Relevant academic research and scientific papers
1-(4-BENZYL-PIPERAZIN-1-YL)-3-PHENYL-PROPENONE DERIVATIVES
-
Page 95, (2010/11/30)
A compound of formula (I), or a pharmaceutically acceptable salt or ester thereof, wherein the symbols have meaning as defined, which are antagonists of CCR-1 and which find use pharmaceutically for treatment of diseases and conditions in which CCR-1 is i
